BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, March 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 17, 2019
View Archived Issues
'CYRI, prevent that infection!'
Read More
Finding MDS' iron fist
Read More
New platform optimizes genome-editing enzyme activity
Read More
Ambrx announces initiation of phase I study of a long-acting relaxin
Read More
Novartis publishes first-in-human data for LYS-228
Read More
AMG-424 demonstrates promising activity in preclinical models of multiple myeloma
Read More
Teplizumab delays progression to clinical type 1 diabetes in relatives at risk
Read More
SAD study data on the anti-phospho-tau antibody JNJ-63733657 in healthy subjects presented
Read More
SHANK3-mutant macaque with altered connectivity and behavior as a model of autism spectrum disorder
Read More
PBD-C06: development candidate for immunotherapy against Alzheimer's disease
Read More
Druggability Technologies begins phase II trial of DRGT-119 for chronic anal fissure
Read More
Sichuan Kelun-Biotech Biopharmaceutical describes bile acid receptor agonists
Read More
mTORC1/mTORC2 inhibitor MTI-31 shows promise for treating lung cancer
Read More
Merck & Co. identifies PI3Kdelta inhibitors
Read More
Chiesi Farmaceutici divulges Rho kinase inhibitors
Read More
Boehringer Ingelheim patents SOS1 inhibitors
Read More
STING is required to restrict MCMV dissemination to lymph nodes
Read More
Bristol-Myers Squibb presents Toll-like receptor antagonists
Read More
Skyhawk and Genentech to discover and develop small-molecule RNA splicing modifiers
Read More
Affibody completes 12-week interim analysis of phase II psoriasis study of ABY-035
Read More
MDA funding supports development of small-molecule drugs to increase sarcospan expression for DMD
Read More
Mallinckrodt discontinues phase IIb study of Acthar gel in ALS
Read More
Researchers in search of small-molecule NAMPT activators for Alzheimer's disease
Read More
FDA clears investigator-initiated phase II trial of GKT-831 for IPF
Read More
Cyclica and University of Toronto enter EGFR inhibitor collaboration
Read More
FDA approves Recarbrio for complicated urinary tract and intra-abdominal infections
Read More
Invio cuts select early R&D programs to focus on HPV-related diseases
Read More
